Connor, Clark & Lunn Investment Management Ltd. - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$210,136
+7.8%
9,724
-3.3%
0.00%0.0%
Q3 2022$195,000
-64.1%
10,061
-44.7%
0.00%
-66.7%
Q1 2022$543,000
+39.2%
18,197
+8.6%
0.00%
+50.0%
Q4 2021$390,00016,7570.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders